Par Drugs and Chemicals Limited — Others, 12-02-2025: Shareholders meeting

Par Drugs and Chemicals Limited held an Extra Ordinary General Meeting where members approved two special resolutions: a slump sale of assets valued at Rs. 95 Crore to Phal-Jig Fine Chemicals Private Limited, and diversifying into real estate, capital markets, and clean energy sectors. The current operations contributed approximately 99.44% to net revenue, prompting this strategic pivot as management sees greater growth potential in these new areas. Investor sentiment may turn positive as the company shifts focus, aiming for enhanced shareholder value through diversification and significant investment in high-growth sectors.